Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Cunningham

Showing results (681-690 of 703) with videos related to

Pageof 71
Sort By:
JACC. Heart Failure|April 4, 2020
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection FractionJonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Journal of Virology|January 24, 2014
Novel gammaherpesviruses in North American domestic cats, bobcats, and pumas: identification, prevalence, and risk factorsRyan M Troyer, Julia A Beatty, Kathryn R Stutzman-Rodriguez, et al.
Journal of Cardiac Failure|March 7, 2023
Missense Genetic Variation of ICAM1 and Incident Heart FailurePedro Giro, Jonathan W Cunningham, Laura Rasmussen-Torvik, et al.
EMBO Reports|October 29, 2024
Phosphorylation of P-stalk proteins defines the ribosomal state for interaction with auxiliary protein factorsKamil Filipek, Sandra Blanchet, Eliza Molestak, et al.
JAMA Cardiology|February 26, 2025
Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical TrialJonathan W Cunningham, Safia Chatur, Brian L Claggett, et al.
European Journal of Heart Failure|May 22, 2023
Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trialSafia Chatur, Jonathan W Cunningham, Muthiah Vaduganathan, et al.
JACC. Basic to Translational Science|October 24, 2024
Proteomic Profile of the <i>ICAM1</i> p.K56M HFpEF Risk VariantPedro Giro, Mallory Filipp, Michael J Zhang, et al.
Annals of Internal Medicine|June 27, 2022
Life Expectancy for White, Black, and Hispanic Race/Ethnicity in U.S. States: Trends and Disparities, 1990 to 2019Catherine O Johnson, Alexandra S Boon-Dooley, Nicole K DeCleene, et al.
Journal of the American College of Cardiology|August 30, 2022
Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection FractionJonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation|October 21, 2024
Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HFLi Shen, Pooja Dewan, João Pedro Ferreira, et al.
Pageof 71

Showing results (681-690 of 703) with videos related to

Sort By:
Pageof 71
JACC. Heart Failure|April 4, 2020
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection FractionJonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Journal of Virology|January 24, 2014
Novel gammaherpesviruses in North American domestic cats, bobcats, and pumas: identification, prevalence, and risk factorsRyan M Troyer, Julia A Beatty, Kathryn R Stutzman-Rodriguez, et al.
Journal of Cardiac Failure|March 7, 2023
Missense Genetic Variation of ICAM1 and Incident Heart FailurePedro Giro, Jonathan W Cunningham, Laura Rasmussen-Torvik, et al.
EMBO Reports|October 29, 2024
Phosphorylation of P-stalk proteins defines the ribosomal state for interaction with auxiliary protein factorsKamil Filipek, Sandra Blanchet, Eliza Molestak, et al.
JAMA Cardiology|February 26, 2025
Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical TrialJonathan W Cunningham, Safia Chatur, Brian L Claggett, et al.
European Journal of Heart Failure|May 22, 2023
Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trialSafia Chatur, Jonathan W Cunningham, Muthiah Vaduganathan, et al.
JACC. Basic to Translational Science|October 24, 2024
Proteomic Profile of the <i>ICAM1</i> p.K56M HFpEF Risk VariantPedro Giro, Mallory Filipp, Michael J Zhang, et al.
Annals of Internal Medicine|June 27, 2022
Life Expectancy for White, Black, and Hispanic Race/Ethnicity in U.S. States: Trends and Disparities, 1990 to 2019Catherine O Johnson, Alexandra S Boon-Dooley, Nicole K DeCleene, et al.
Journal of the American College of Cardiology|August 30, 2022
Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection FractionJonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation|October 21, 2024
Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HFLi Shen, Pooja Dewan, João Pedro Ferreira, et al.
Pageof 71